ArticleSubstance abuse : research and treatment2020
Can a Smartphone App for Cannabis Cessation Gain a Broader User Group than Traditional Treatment Services?
Article in Substance abuse : research and treatment, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 15 citations in OpenAlex.
- A Mobile App (Joint Effort) to Support Cannabis Use Self-Management and Reinforce the Use of Protective Behavioral Strategies: Development Process and Usability Testing.JMIR formative research · 2025Article
- Gradual improvement in functioning and mental distress during long-term outpatient SUD treatment - A prospective pre-post study.Addictive behaviors reports · 2024Article
- Evaluating the effectiveness of a mobile app-based self-guided psychological interventions to reduce relapse in substance use disorder: protocol for a randomized controlled trial.Frontiers in psychiatry · 2024Article
- Use of the Therapy App Prescinde for Increasing Adherence to Smoking Cessation Treatment.Healthcare (Basel, Switzerland) · 2023Article
- The use and effects of telemedicine on complementary, alternative, and integrative medicine practices: a scoping review.BMC complementary medicine and therapies · 2023Article
- The Craving-Manager smartphone app designed to diagnose substance use/addictive disorders, and manage craving and individual predictors of relapse: a study protocol for a multicenter randomized controlled trial.Frontiers in psychiatry · 2023Article
- Successful outcomes with low-threshold intervention for cannabis use disorders in Norway - an observational study.PloS one · 2022Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTreatment demand for cannabis use disorders is increasing in Europe. Mobile phone- and internet-based interventions for cannabis users can possibly help meet the need. The purpose of this study was to examine whether a recently developed Norwegian Cannabis Cessation app reaches a broader or different user group compared to community-based Cannabis Cessation programs (CCP, Nordic abbreviation: HAP).
methodThe app respondents (n = 148) were recruited through an online link in the app. A comparative sample (n = 102) was recruited in three municipally based CCPs in Norway. We examined whether app users differed from the CCP population in sociodemographics, substance use, mental health, and well-being.
resultThe app group included more women than the CCP group (46% versus 26%, χ
conclusionThe higher proportion of women in the app group indicated that the app did capture an expanded segment of the cannabis-using population. The app can be an alternative for those who are not yet prepared to seek treatment in formal healthcare services. The high level of depressive symptoms and lower levels of well-being among the app respondents suggest that some app users might need additional support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.